LABT - Lakewood-Amedex Biotherapeutics Highlights Nu-3 Resistance Data in Response to National Action Plan of Presidential Advisory Council
LABT - Lakewood-Amedex Biotherapeutics Highlights Nu-3 Resistance Data in Response to National Action Plan of Presidential Advisory Council on Combating Antibiotic Resistant Bacteria
Story updates
12:10:27 PM UTC
SquawkNews
Top Small Cap Positive News Movers Premarket: LABT: +144% Highlights Nu-3 Resistance Data in Response to National Action Plan of Presidential Advisory Council on Combating Antibiotic Resistant Bacteria INLF: +53% Momentum Mover CHAI: +49% Momentum Mover INM: +45% $200 Million Private Placement for Migraine Prevention Pipeline SXTC: +45% Momentum Mover AEHL: +42% Momentum Mover ZCMD: +29% Momentum Mover ADVB: +21% Momentum Mover KUST: +18% Momentum Mover
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.